Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50 GBX | +0.60% | 0.00% | -13.19% |
04-24 | Calliditas Therapeutics AB Announces Positive NefIgArd Open Label Extension Results | CI |
04-22 | Capital & Regional picks Gerry Murphy as non-exec director | AN |
Sales 2023 * | 23.99M 29.97M 2.4B | Sales 2024 * | 27.18M 33.95M 2.72B | Capitalization | 110M 137M 10.95B |
---|---|---|---|---|---|
Net income 2023 * | 15M 18.74M 1.5B | Net income 2024 * | 19M 23.73M 1.9B | EV / Sales 2023 * | 10.9 x |
Net Debt 2023 * | 152M 190M 15.17B | Net Debt 2024 * | 157M 196M 15.7B | EV / Sales 2024 * | 9.81 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 350 |
Yield 2023 * |
11.4% | Yield 2024 * |
12% | Free-Float | 18.71% |
Latest transcript on Capital & Regional plc
1 day | +0.60% | ||
Current month | -3.66% | ||
1 month | -3.47% | ||
3 months | -10.07% | ||
6 months | -7.75% | ||
Current year | -13.19% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 12/06/17 | |
Stuart Wetherly
DFI | Director of Finance/CFO | - | 30/09/12 |
Sara Jennings
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leon Sasse
BRD | Director/Board Member | 59 | 08/12/19 |
Ian Krieger
BRD | Director/Board Member | - | 30/11/14 |
Laura Whyte
BRD | Director/Board Member | - | 30/11/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 50 | +0.60% | 37,307 |
25/04/24 | 49.7 | -0.60% | 122,079 |
24/04/24 | 50 | +0.10% | 24,665 |
23/04/24 | 49.95 | -0.10% | 205,587 |
22/04/24 | 50 | 0.00% | 248,802 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.19% | 136M | |
-0.20% | 46.38B | |
-13.75% | 12.39B | |
-22.69% | 11.06B | |
-13.01% | 10.74B | |
-5.43% | 7.45B | |
-6.66% | 6.54B | |
-8.23% | 5.8B | |
-7.60% | 5.6B | |
-7.00% | 4.67B |
- Stock Market
- Equities
- CAL Stock